Novel insulins and strict glycemic control
Authors:
- John R. WhiteJWJohn R. White
- R. Keith CampbellRCR. Keith Campbell
- Irl B. HirschIHIrl B. Hirsch
- Pa- CPCPa- C
- Pharm DPDPharm D
- RphRPRph
- CdeCDCde
- MdMDMd
- 30 June 2003
- journal article
- research article
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 113 (6) , 30-36
Abstract
Our ability to gain strict glycemic control in diabetes has improved with the introduction of novel insulins. New formulations, novel insulin molecules, and various methods of insulin delivery are able to more closely approximate the normal physiologic insulin response than conventional preparations. In this article, the authors review the development of insulin formulations and the pharmacology of currently available insulin molecules and those soon to be on the market.Keywords
This publication has 12 references indexed in Scilit:
- Insulin therapy in type 2 diabetes.Journal of the American Pharmaceutical Association, 2002
- Insulin Glargine: A New Basal InsulinAnnals of Pharmacotherapy, 2002
- Insulin Aspart: A New Rapid-Acting Insulin AnalogAnnals of Pharmacotherapy, 2000
- Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.Diabetes Care, 2000
- Improved postprandial glycemic control during treatment with Humalog Mix25, a novel protamine-based insulin lispro formulation. Humalog Mix25 Study Group.Diabetes Care, 1999
- Comparative pharmacokinetics and pharmacodynamics of the novel rapid-acting insulin analogue, insulin aspart, in healthy volunteersEuropean Journal of Clinical Pharmacology, 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Insulin analoguesPostgraduate Medicine, 1997
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Monomeric Insulins and Their Experimental and Clinical ImplicationsDiabetes Care, 1990